Clinical Trial: Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

U.S., Oct. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07217587) titled 'Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis' on Oct. 15.

Brief Summary: The purpose of this study is to assess how well nipocalimab works when compared to efgartigimod in participants with generalized myasthenia gravis (a condition in which body's immune system mistakenly attacks and damages the connection between nerves and muscles causing muscle weakness).

Study Start Date: Nov. 28

Study Type: INTERVENTIONAL

Condition: Myasthenia Gravis

Intervention: DRUG: Nipocalimab

Nipocalimab will be administered intravenously.

DRUG: Efgartigimod

Efgartigimod will be administ...